Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
12 Sep 2024 |
PSC05 |
Change of details for Haleon Uk Holdings (No.3) Limited as a person with significant control on 1 September 2021
|
|
|
11 Sep 2024 |
CS01 |
Confirmation statement made on 11 September 2024 with updates
|
|
|
22 Aug 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
17 Oct 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
10 Oct 2023 |
PSC05 |
Change of details for Haleon Uk Holdings (No.3) Limited as a person with significant control on 18 July 2022
|
|
|
06 Oct 2023 |
PSC05 |
Change of details for a person with significant control
|
|
|
05 Oct 2023 |
PSC05 |
Change of details for Gsk Consumer Healthcare Holdings (No.3) Limited as a person with significant control on 18 August 2023
|
|
|
14 Sep 2023 |
CS01 |
Confirmation statement made on 14 September 2023 with updates
|
|
|
01 Jun 2023 |
CH04 |
Secretary's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
01 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
01 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
15 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
15 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
15 May 2023 |
CH04 |
Secretary's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
17 Feb 2023 |
CERTNM |
Company name changed glaxosmithkline consumer healthcare (uk) trading LIMITED\certificate issued on 17/02/23
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2023-01-27
|
|
|
03 Jan 2023 |
AA |
Full accounts made up to 31 December 2021
|
|
|
07 Oct 2022 |
CS01 |
Confirmation statement made on 26 September 2022 with updates
|
|
|
12 Sep 2022 |
TM01 |
Termination of appointment of Aidan Lynch as a director on 30 June 2022
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
06 Apr 2022 |
AP04 |
Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a secretary on 6 April 2022
|
|
|
06 Apr 2022 |
TM02 |
Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a secretary on 6 April 2022
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of Glaxo Group Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022
|
|